Ann: PTX agreement with Thermo Fisher for scalable OmniCAR, page-69

Nice find, hottod. Thermo Fisher is huge in China according to the Jim Cramer interview with the CEO of TH. I note that the first presentation mentions the "emergerging Asian market". A number of Asian countries have outstanding start-of-the-art hospitals and clinicians. There is also a growing attraction for undertaking clinical trials in places like Thailand, India and the Phillipines due to the cost and expediency that their regulatory process avails. I wonder if SYC gives consideration to running clinical trials in Asia in the near future...?

Anyway, its clear that our team have been and continue to be busy on the corporate front. I'm sure that Dan Shelly will have emphasised our deals with TH and Q-Gen in his presentation at the Annual Bioprocessing Summit this week in Boston.